Researchers shared findings today at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans. San ...
Abbott (NYSE:ABT) today announced new clinical data highlighting the importance of managing diabetic ketoacidosis (DKA).
Senseonics (NYSE:SENS) today announced real-world evidence supporting the performance of its Eversense 365 year-long CGM ...
Insulet announced today that it is rolling out new algorithm enhancements for its Omnipod 5 automated insulin delivery system ...
Tidepool has new clinical insights and research initiatives related to diabetes management and automated insulin delivery ...
MyLife Diabetes Care, CamDiab and Dexcom today announced the integration of the G7 continuous glucose monitor (CGM) into the ...
The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced new clinical findings for its next-generation Omnipod 6 and fully closed-loop algorithm. The company ...
Apollon and an MIT lab today shared clinical findings demonstrating the accuracy of their non-invasive continuous glucose ...
MiniMed (Nasdaq:MMED) announced today that it expanded its agreement with Abbott (NYSE:ABT) to add more sensors to its ...
PharmaSens said that it enrolled the first patient in a clinical feasibility study of its all-in-one automated insulin patch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results